Mr. Akram Bouchenaki

Akram Bouchenaki is Chief Executive Officer of Abdul Latif Jameel Health, Abdul Latif Jameel’s health care business, focusing on accelerating access to modern medical care while addressing unmet medical needs in emerging markets around the World.  Abdul Latif Jameel Health is part of Abdul Latif Jameel, a collective of independent international, family-owned and diversified businesses, founded in 1945 by the late Abdul Latif Jameel. 

Mr. Bouchenaki joins Abdul Latif Jameel Health after 25 years of operational and strategic roles in the pharmaceutical and healthcare sectors, including global leadership roles in ‘big-pharma’ corporates like Bristol Myers Squibb and GSK, as well as over a decade in top California-based biotech Gilead, where he was an executive director for Africa covering the largest markets on the continent. 

Akram has extensive knowledge and experience of both generics and branded medicines in established as well as key emerging markets across the world.  These include Africa’s most significant markets, Brazil, and Mexico, having co-founded a fast-growing start-up to commercialize medicines in Latin America. 

Akram holds a Doctorate in Pharmacy from Université de Paris V, France.  He has lived and worked in 9 different countries across 5 continents. He speaks French, Spanish, Arabic, Portuguese and English.